Literature DB >> 2575488

Differential regulation of oncogenic and cellular p185 by serine/threonine kinases.

K Dobashi1, D B Weiner, M I Greene.   

Abstract

185c-neu is a member of a family of growth factor receptors with tyrosine kinase activity. A point mutation in the transmembrane region leads to activation of the enzymatic domain. We demonstrate that TPA (phorbol-12-myristate-13-acetate) stimulates the phosphorylation of p185c-neu on serine and threonine residues coincident with the inhibition of its intrinsic tyrosine kinase and the proliferation of cells that express it. The tyrosine kinase activity as well as the phosphorylation pattern of serine and threonine residues of oncogenic p185 (p185neu) and the growth of p185neu-expressing cells are not influenced by TPA. These observations indicate that the functional activity of p185c-neu can be regulated through protein kinase C (PKC) but the transmembrane point mutation present in p185neu renders it refractory to serine/threonine kinase regulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575488     DOI: 10.1089/dna.1989.8.723

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  8 in total

1.  Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.

Authors:  Y Mikami; J G Davis; K Dobashi; W C Dougall; J N Myers; V I Brown; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.

Authors:  George Vlotides; Emily Siegel; Ines Donangelo; Shiri Gutman; Song-Guang Ren; Shlomo Melmed
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Modulatory effect of the transmembrane domain of the protein-tyrosine kinase encoded by oncogene ros: biological function and substrate interaction.

Authors:  C S Zong; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.

Authors:  Jaekwang Jeong; Jungmin Choi; Wonnam Kim; Pamela Dann; Farzin Takyar; Julia V Gefter; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

5.  Characterization of a neu/c-erbB-2 protein-specific activating factor.

Authors:  K Dobashi; J G Davis; Y Mikami; J K Freeman; J Hamuro; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Heregulin regulates prolactinoma gene expression.

Authors:  George Vlotides; Odelia Cooper; Yen-Hao Chen; Song-Guang Ren; Yona Greenman; Shlomo Melmed
Journal:  Cancer Res       Date:  2009-04-28       Impact factor: 12.701

7.  p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.

Authors:  X L Quian; S J Decker; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

8.  Exploring Different Effects of Exclusive Enteral Nutrition (EEN) and Corticosteroids on the Gut Microbiome in Crohn's Disease Based on a Three-Stage Strategy.

Authors:  Dong Guo; Liang Fang; Ruiqing Liu; Yu Li; Liang Lv; Zhaojiao Niu; Dong Chen; Yanbing Zhou; Weiming Zhu
Journal:  Gastroenterol Res Pract       Date:  2022-07-27       Impact factor: 1.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.